General Information:
Id: | 9,896 |
Diseases: |
Ciliary dyskinesia, primary
Ciliopathy |
Homo sapiens | |
article | |
Reference: | Fedick AM et al.(2015) Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population Mol Genet Genomic Med 3: 137-142 [PMID: 25802884] |
Interaction Information:
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103851 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103978 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103979 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103980 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103981 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103982 |
|
Comment | Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation. |
Formal Description Interaction-ID: 103983 |
|